Home / Joy Pape, MSN, FNP-C, CDE, WOCN, CFCN, FAADE

Joy Pape, MSN, FNP-C, CDE, WOCN, CFCN, FAADE

Joy Pape, MSN, FNP-C, CDE, WOCN, CFCN, FAADE
(Associate Medical Editor Diabetes In Control) Clinical Nurse Practitioner, CDE, Comprehensive Weight Control Center, Weill Cornell Medical College; President of EnJoy Life! Health Consulting, New York City, NY; co-author of the Real-Life Guide to Diabetes; Immediate Past President for the Metropolitan New York Association of the American Diabetes Association of Diabetes Educators (MNYADE). As an internationally known family nurse practitioner (FNP) and certified diabetes educator (CDE), Joy Pape specializes in diabetes, weight management, home blood pressure monitoring, sleep, and foot care. She is the co-author of the Real-Life Guide to Diabetes (The American Diabetes Association). She writes for several national magazines, is a dynamic national motivational presenter for both health-care professionals and the general public, and is a partner of Laugh it Off! a health edutainment team. Joy says, “Most important is that I still see patients. That is my passion…to connect with my patients so that together we can help them reach their optimum health.

PCOS: Motivate Young Women to Make Changes

Young woman, 15 years of age, presented with class II obesity (BMI 37), irregular periods, hirsutism, and continuing to gain weight. Her first visit was with her mother. We met and discussed the possibility of her having polycystic ovarian syndrome because of her symptoms. We confirmed with labs.

Read More »

Andrea Dunaif 2018 Complete Interview

Andrea Dunaif, M.D., is the Lillian and Henry M. Stratton Professor of Molecular Medicine and Chief of the J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Icahn School of Medicine at Mount Sinai, New York, NY. Dr. Dunaif is an internationally recognized expert in endocrinology and women’s health. Her research on polycystic ovary syndrome (PCOS), the most common hormonal disorder of reproductive-age women, has shown that it is a leading risk factor for type 2 diabetes mellitus. Further, this research has revolutionized the treatment of PCOS with insulin sensitizing drugs.

Read More »